Assistant Professor Paula Cuccaro, PhD; Professor Ross Shegog, PhD; and Associate Professor Lara Savas, PhD, were awarded $3,996,163 from the Cancer Prevention and Research Institute of Texas (CPRIT) to develop adolescent cancer prevention research. These awards were part of a $100 million grant to continue Texas's initiatives to build cancer research and represent the country's most significant state initiative to combat cancer.
The American Heart Association (AHA) awarded a cumulative $1.2 million to UTHealth Houston School of Public Health researchers to test the effectiveness of Food is Medicine interventions to improve maternal and infant health outcomes.
Three commitments to improve food security, diet quality, and health outcomes for vulnerable communities, made by UTHealth Houston in partnership with local and national organizations, have been approved as part of the White House Challenge to end Hunger and Build Healthy Communities.
UTHealth Houston is a national leader in National Institutes of Health (NIH) research funding, according to annual rankings released by the Blue Ridge Institute for Medical Research.
September 20, 2022
Adolescent and young adult women who were diagnosed with cancer and received chemotherapy treatment prior to pregnancy did not have a higher risk of stillbirth, according to research led by Caitlin C. Murphy, PhD, MPH, with UTHealth Houston.
September 19, 2022
Adolescents suffering with severe obesity who underwent bariatric surgery before the age of 22 had significant and lasting reductions in weight and comorbidities after surgery, according to researchers from UTHealth Houston and the University of Miami.
September 1, 2022
A clinical trial investigating the effects of different treatments, including light exercise and screen time restrictions, on recovery from a sport-related concussion among adolescents has opened for enrollment at UTHealth Houston.
August 8, 2022
While research has revealed that children and adults hospitalized with COVID-19 are more susceptible to developing long COVID symptoms, a new study by researchers at UTHealth Houston found that children infected with COVID-19, but not hospitalized, still experienced long COVID symptoms up to three months past infection.
The study was published in The Pediatric Infectious Disease Journal.
June 30, 2022
Researchers at UTHealth School of Public Health have been selected to receive $1 million from a $3.4 million grant to address the opioid epidemic and identify overdose patterns.
June 29, 2022
Providing caregivers easy access to produce and flexible resources can lead to improvements in kids’ diets in a short time, according to a new study co-authored by researchers with UTHealth School of Public Health together with researchers from Dell Medical School at The University of Texas at Austin.
May 31, 2022
Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.
The findings were published in The Journal of Infectious Diseases.
March 23, 2022
The Cancer Prevention and Research Institute of Texas (CPRIT) awarded over $6 million to researchers with UTHealth Houston to aid in cancer prevention research. These awards will expand liver cancer prevention to persons experiencing homelessness, facilitate communication about the HPV vaccine, and find therapeutics that can help destroy gastrointestinal cancer cells.
March 18, 2022
Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.
March 3, 2022
The incidence of cervical cancer is starting to rise in low-income U.S. counties and has plateaued in high-income counties in recent years, after years of decreases, according to a new study led by investigators from The University of Texas Health Science Center at Houston (UTHealth Houston) and published in JNCI Cancer Spectrum.
